Journal of Psychedelic Studies
April 2, 2024
Sonia M. Brodie, Chelsea Stunden, Jay A. Olson et al.
AbstractBackground and aimsFirst responders such as firefighters and police officers often experience traumatic events as part of their work. As a result, they are more likely to have mental health issues such as post-traumatic stress disorder, depression, and anxiety compared to the general population. Psychedelic-assisted therapy has emerged as a promising avenue to alleviate these issues,...
European Psychiatry
April 1, 2024
V. Tsang
IntroductionDepression continues to present significant economic burdens to the Canadian healthcare system. Novel therapies, including those that incorporate psychoactive substances such as ketamine, present an opportunity to evaluate both clinical and economic effectiveness against current standards of care, which may be repeatedly proving ineffective in treating depression for some...
International Journal of Mental Health and Addiction
April 1, 2024
Joseph T. Torre, Mehdi Mahammadli, Sonya C. Faber et al.
31 citations
Currently, individuals with personal or familial histories of psychopathological experiences of psychosis, psychotic spectrum disorders, bipolar disorder, and similar conditions are excluded from most psychedelic clinical trials, studies, and treatment programs. This study sought to determine why such an exclusion exists, what the implications of the exclusion criteria are, and if there was...
European Psychiatry
April 1, 2024
N. Kabir, B. Anderson, Lisa Bouchet et al.
1 citation
Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...
European Psychiatry
April 1, 2024
Shannon Dames, Crosbie Watler, P. Kryskow et al.
1 citation
Introduction This review explores the benefits of incorporating personal experience(s) with non-ordinary states of consciousness as a core component of Psychedelic-Assisted Therapy (PaT) training.The program incorporates an optional experiential training component. We collaborate with professionals affiliated with a Canadian non-profit organization specializing in PaT experiential training. As...
Journal of Behavioral Addictions
March 26, 2024
Pedro Romero, Andrea Czakó, Wim van den Brink et al.
7 citations
Abstract Gambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder. Recent studies have shown promising results using...
Psychoactives
March 25, 2024
Agnieszka D. Sekula, Prashanth Puspanathan, Luke A. Downey et al.
1 citation
A set of interventions that can produce altered states of consciousness (ASC) have shown utility in the treatment of substance misuse. In this review, we examine addiction-related outcomes associated with three common interventions that produce ASCs: psychedelic-assisted psychotherapy (PP), Transcendental Meditation (TM) and hypnotherapy (HT). While procedurally distinct, all three...
Frontiers in Artificial Intelligence and Applications
March 22, 2024
Yixin Yu, Yashi Shuai, Ran Wan
This study aimed to explore the effect of artificial intelligence-generated artwork (AIGC) as an adjunct to mindfulness meditation on the improvement of anxiety symptoms in retired people. We recruited a group of retired people with anxiety symptoms and randomly divided them into two groups: the mindfulness meditation group (N=20) and the mindfulness meditation +AIGC group (N=20). The...
Neuroethics
March 16, 2024
Nicolas Langlitz, Alex K. Gearin
26 citations
Abstract In the historical context of a crisis in biological psychiatry, psychedelic drugs paired with psychotherapy are globally re-emerging in research clinics as a potential transdiagnostic therapy for treating mood disorders, addictions, and other forms of psychological distress. The treatments are poised to soon shift from clinical trials to widespread service delivery in places like...
Mental Health Weekly
March 11, 2024
Valerie A. Canady
In response to the psychological trauma inflicted by the ongoing conflict in Ukraine, Fluence, a leader in comprehensive, evidence‐based training in psychedelic therapy announced last week a collaboration with the Ukrainian Psychedelic Research Association (UPRA) and the U.S. nonprofit Health Ukraine Trauma (HUT), to provide free training in psychedelic therapy to Ukrainian psychologists and...